Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Helen F. Graham Cancer Center
& Research Institute

Sarcoma, Bone Cancer and Melanoma

A sarcoma is a cancer that begins in the bone, cartilage, muscle, fat, blood vessels or other connective or supportive tissue of the body. The Helen F. Graham Cancer Center & Research Institute’s Sarcoma, Bone Cancer and Melanoma Multidisciplinary Center specializes in treating soft-tissue sarcomas of the trunk and extremities, retropertioneal sarcomas and bone sarcomas. We also specialize in treating melanomas, which is a type of cancer that begins in the cells that produce the pigment melanin. Melanoma may begin as a mole on the skin, but it can also begin in other pigmented tissues, such as in the eye or intestines.

Your multidisciplinary team

Surgery, chemotherapy and radiation are used to treat these cancers. Decades of clinical experience show that combinations of these treatments often are most effective. Your team will tailor your cancer treatment for your cancer and for you.

When you visit the Helen F. Graham Cancer Center & Research Institute, you will meet with a team of doctors in one visit:

  • Your surgeon can order diagnostic tests, perform a biopsy to see if your tumor is malignant or operate to remove cancer if necessary.
  • Your medical oncologist can administer chemotherapy or immunotherapy that kills cancer cells.
  • Your radiation oncologist can pinpoint places where your cancer is growing and use precisely focused X-rays to reduce or destroy it.

Together, these specialists, in consultation with your primary-care doctor and with the support of your care-management team, will work with you to create the most appropriate and effective plan of treatment for your cancer.

Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
302-623-4500